Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?

Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?

(1) Background: In recent years, “new” direct oral anticoagulants (DOAC) have gradually replaced other antithrombotic therapies. The international literature agrees on the increased mortality for traumatic brain injury (TBI) patients using vitamin K antagonists (VKA), but thus far, there are insuffi...

Full description

Bibliographic Details
Main Authors: Anna Antoni, Lukas Wedrich, Martin Schauperl, Leonard Höchtl-Lee, Irene K. Sigmund, Markus Gregori, Johannes Leitgeb, Elisabeth Schwendenwein, Stefan Hajdu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
traumatic brain injury
antithrombotic therapy
DOAC
NOAC
direct oral anticoagulants
Online Access:https://www.mdpi.com/2077-0383/11/21/6268

Internet

https://www.mdpi.com/2077-0383/11/21/6268

Similar Items